MRI Relaxometry: T1/T2 Mapping Phantom QC

Introduction

MRI relaxometry is the quantitative measurement of tissue relaxation times, and a phantom-based QC program is what makes those numbers trustworthy across scanners and over time. Where conventional MRI produces relative gray-scale contrast, relaxometry assigns each voxel a physical value in milliseconds — a T1, T2, or T2* — that can be compared to a diagnostic threshold, to the same patient last year, or to a scanner across town. That promise only holds if the measurement is accurate and stable.

Quantitative T1 and T2 mapping has moved from a research curiosity to routine clinical practice, most visibly in cardiac MRI, where native T1, T2, and extracellular volume (ECV) maps detect diffuse fibrosis, edema, iron overload, and infiltration that ordinary images miss. ^{1, 7} But the measured relaxation time depends on far more than the tissue: it shifts with the pulse sequence, field strength, vendor, software version, and even the temperature of the phantom used to check it. ^{2, 3, 4} A T1 that reads 1000 ms on one platform can read 940 ms on another for the same object, and a 6 percent difference is enough to move a patient across a decision boundary.

This guide explains the physics behind T1 and T2 mapping, the reference phantoms that anchor the measurement, and how to build a defensible relaxometry quality control (QC) program — one that quantifies bias against known values, tracks repeatability, and controls the temperature and workflow variables that quietly corrupt quantitative results. DRPS provides this analysis as part of its MRI physics testing and accreditation support services across Florida, Maryland, Virginia, Washington DC, California, and Nevada.

Topic Explanation

What relaxometry actually measures

Relaxometry recovers the intrinsic time constants that govern how nuclear magnetization returns to equilibrium after excitation. After a radiofrequency pulse tips the net magnetization away from the main field, two independent processes restore it. Longitudinal magnetization recovers along the field with time constant T1 (spin–lattice relaxation), and transverse magnetization decays with time constant T2 (spin–spin relaxation). A relaxometry sequence samples this recovery or decay at several time points and fits the physical model to extract T1 or T2 per voxel.

Because these constants are properties of the tissue microenvironment — water content, macromolecular concentration, iron, fat, and field strength — they carry biological meaning. Native (pre-contrast) myocardial T1 rises with edema, amyloid, and fibrosis and falls with iron or fat; T2 rises with edema; and ECV, derived from pre- and post-contrast T1 in blood and myocardium, estimates the interstitial space. ⁷ The clinical value of these biomarkers is precisely why the measurement must be quantitatively correct, not merely reproducible in appearance.

For related quantitative MRI QC that shares this philosophy of measuring a physical value rather than contrast, see our companion articles on MRI diffusion (DWI/ADC) quantitative QC and MRI SNR and RF coil QC.

Why mapping is harder than it looks

A single T1 or T2 map hides a chain of assumptions. The fitting model assumes ideal pulses, perfect inversion, negligible off-resonance, and no confounding from the other relaxation process. Real sequences violate these to varying degrees. The widely used cardiac MOLLI (Modified Look-Locker Inversion recovery) family, for example, is fast and robust but systematically underestimates T1 because of magnetization-transfer and imperfect inversion effects, while a slow inversion-recovery spin-echo reference is accurate but clinically impractical. ^{3, 4} The consequence is that "T1" is not one number — it is a number attached to a specific acquisition, and a QC program has to treat it that way.

Key Technical Principles

The signal models a QC program must fit

For a saturation- or inversion-based T1 measurement, longitudinal magnetization recovers exponentially. A spoiled/saturation recovery obeys:

S (T R) = S_{0} (1 - e^{- T R / T_{1}})

while an inversion-recovery experiment, which inverts the magnetization first, follows:

S (T I) = S_{0} (1 - 2 e^{- T I / T_{1}})

The inversion-recovery signal passes through zero at the null time, giving a clean way to check a T1 value. Setting the bracket to zero:

0 = 1 - 2 e^{- T I_{n u l l} / T_{1}} \Rightarrow T_{1} = \frac{T I _{n u l l}}{ln 2}

Transverse magnetization, sampled by a multi-echo spin-echo or T2-preparation sequence, decays as:

S (T E) = S_{0} e^{- T E / T_{2}}

Fast T1 methods often use the variable-flip-angle (VFA) spoiled gradient echo, which linearizes to a form whose slope yields T1:

\frac{S}{sin α} = e^{- T R / T_{1}} \frac{S}{tan α} + M_{0} (1 - e^{- T R / T_{1}})

A relaxometry QC program does not just accept the scanner's map — it re-fits or verifies these models against an object whose true values are known.

Worked example: turning a null time into a T1 and a bias

Suppose an inversion-recovery scan of an ISMRM/NIST phantom sphere shows the signal nulling at an inversion time of $T I_{n u l l} = 693 ms$ . The measured T1 is:

T_{1} = \frac{693 ms}{ln 2} = \frac{693}{0.693} = 1000 ms

If the NMR-assigned reference value for that sphere is $T_{1, ref} = 989 ms$ , the bias is:

bias = \frac{T _{1, meas} - T _{1, ref}}{T _{1, ref}} \times 100% = \frac{1000 - 989}{989} \times 100% \approx + 1.1%

Now suppose the site's clinical MOLLI sequence reads the same sphere at 940 ms. Its bias is $(940 - 989) /989 = - 5.0%$ . Both numbers are "correct" for their sequence, but only a QC program that records the reference value and the sequence makes that 6-percentage-point spread visible and actionable.

Accuracy and precision as separate quantities

Accuracy (bias) and precision (repeatability) are distinct and must be tracked separately. Precision is quantified with the coefficient of variation over repeated scans:

CoV = \frac{σ}{x ˉ} \times 100%

The multi-national T1MES phantom program reported that, after adjusting for temperature and field strength, several specific sequence, field-strength, and scanner combinations achieved native-T1 CoVs on the order of 1 percent or less — for example, a 1.5 T MOLLI variant near 0.3 percent — while other combinations were markedly worse. ⁴ That result sets a realistic internal target: a mature single-site program should hold short-term repeatability at or below roughly 1 percent for its clinical mapping sequence, and should investigate any step change in bias.

Comparison of common relaxometry methods

Method	Measures	Speed	Accuracy vs. NMR reference	Main QC caveat
Inversion-recovery spin-echo	T1	Very slow (reference only)	Highest; used to assign phantom values	Impractical clinically; long TR needed for full recovery
Variable flip angle (DESPOT1/SPGR)	T1	Fast	Moderate; sensitive to B1 errors	Requires accurate B1 mapping and flip-angle calibration ²
MOLLI / ShMOLLI	T1 (cardiac)	Fast, breath-hold	Underestimates T1; heart-rate and MT sensitive	Vendor/sequence-specific; must compare to matched reference ^{3, 4}
Multi-echo spin-echo	T2	Moderate	Good; stimulated echoes bias fits	Needs many echoes and stimulated-echo correction
T2-prepared bSSFP	T2 (cardiac)	Fast, breath-hold	Moderate; T1 contamination	Sequence- and field-specific reference values required ⁷
MR fingerprinting	T1 and T2	Fast, simultaneous	High cross-system reproducibility reported	Dictionary and hardware dependence; still maturing ⁵

The table's central message is that no single method is both fast and reference-accurate, so a QC program benchmarks the site's clinical sequence against a slow reference or a characterized phantom rather than assuming the fast method is truth.

Clinical Impact

When relaxometry drifts, the error lands directly on a diagnostic threshold. Cardiac T1 and T2 mapping are used with reference ranges that a site establishes for its own scanner and sequence; a shift of a few percent in the phantom bias signals that the site-specific normal range may no longer apply. ^{4, 7} Because native T1 rises only modestly in some diffuse disease, a systematic bias comparable in size to the pathological change can either mask disease or fabricate it.

The problem compounds across scanners. A patient scanned on a 1.5 T system at baseline and a 3 T system at follow-up will show a large apparent T1 change purely from field strength, and even two 3 T scanners from different vendors can disagree beyond the effect being measured. ^{2, 3} Multi-site and longitudinal studies — and increasingly routine care in multi-scanner health systems — depend on relaxometry QC to separate real biological change from platform variance. The same reasoning underlies quantitative ADC standardization, and the failure mode is identical: a number that looks authoritative but is not comparable.

Quantitative mapping also raises the stakes for ordinary hardware faults. A subtle B1 transmit error that a radiologist would never notice on a clinical image directly biases a VFA T1 map, and gradient or temperature instability that is invisible on anatomy corrupts the fit. ² Relaxometry QC therefore doubles as a sensitive early-warning system for scanner health, complementing the ACR phantom QC and B0 homogeneity and center-frequency checks already in place.

Practical Optimization Tips

A defensible relaxometry QC program follows a consistent workflow.

1. Choose and characterize the phantom

Use a phantom with traceable reference values spanning the clinical range. The ISMRM/NIST system phantom provides NMR-characterized T1 and T2 sphere arrays for general quantitative MRI, while the T1MES phantom is purpose-built and regulatory-cleared for cardiac T1 and ECV. ^{4, 5, 6} Record the phantom serial number, reference table, and the temperature at which the values are quoted.

2. Control temperature

Relaxation times are temperature dependent, so let the phantom equilibrate in the scanner room and measure and record its temperature at every scan. The T1MES program found long native-T1 tubes changed by roughly 11 ms per degree Celsius for a 1.5 T MOLLI variant, so an uncontrolled few-degree swing can dwarf the drift you are trying to detect. ⁴ Apply the vendor's temperature correction or restrict comparisons to a documented temperature window.

3. Match the acquisition to the clinic

Scan the phantom with the exact clinical mapping sequence, field strength, coil, and software version you use on patients, and also acquire a slow reference (inversion-recovery for T1, multi-echo for T2) at acceptance to anchor the bias. Changing any of these variables invalidates the prior baseline.

4. Analyze consistently

Place fixed regions of interest inside each sphere or tube, avoiding edges and susceptibility artifact, and use the same ROI definitions and fitting software each time. Compute bias against the reference value and CoV across repeats, and log both.

5. Trend, don't just pass/fail

Plot bias and repeatability over time. A single in-tolerance result is less informative than a stable trend; a step change after a software update or coil swap is the signal you are looking for. Tie the review to the annual medical physicist evaluation.

Common pitfalls to avoid

Comparing across sequences as if they were interchangeable. MOLLI, ShMOLLI, and inversion-recovery give different T1 values for the same object by design. ^{3, 4}
Ignoring temperature. Uncontrolled phantom temperature is the most common source of spurious drift in native-T1 QC. ⁴
Trusting the fast method as truth. VFA T1 is only as good as the B1 calibration behind it. ²
Changing ROIs or software between sessions. Analysis drift masquerades as scanner drift.
Assuming ACR accreditation covers relaxometry. The ACR phantom validates geometry, uniformity, and resolution — not absolute relaxation times.

Regulatory Considerations

No federal rule sets a numeric tolerance for quantitative T1 or T2, so relaxometry QC lives at the intersection of accreditation requirements, consensus recommendations, and the facility's own validated protocol. The ACR MRI Quality Control Manual (2015) and the ACR MRI Accreditation Program Requirements define the weekly technologist QC, the annual medical physicist evaluation, and the phantom tests for geometric accuracy, resolution, slice parameters, uniformity, ghosting, and low-contrast detectability — the accredited backbone on which relaxometry QC builds. ⁸ Because MRI is non-ionizing, it falls outside the FDA/state radiation-machine programs that govern x-ray and CT; there is no MQSA-style federal mapping mandate.

Instead, the authorities that matter for quantitative mapping are consensus and standards documents. The Society for Cardiovascular Magnetic Resonance (SCMR) consensus on T1, T2, T2*, and ECV mapping gives the clinical framework and stresses site- and sequence-specific reference ranges and quality assurance. ⁷ NEMA MS standards define how SNR and uniformity are measured, IEC 62464-1 specifies MR equipment characteristics and test methods, and Quantitative Imaging Biomarkers Alliance (QIBA) profiles describe how to claim a quantitative measurement with a stated bias and repeatability. The Joint Commission's diagnostic imaging standards require an annual MRI equipment performance evaluation by a qualified medical physicist or MR scientist, which is the natural home for reviewing the relaxometry trend.

Of the states DRPS serves, MRI performance requirements flow through ACR accreditation and Joint Commission surveys rather than a radiation-control program, because the modality is non-ionizing. A facility offering quantitative mapping as a clinical service should document its validation protocol, reference phantom, temperature control, and acceptance criteria so the program is defensible during accreditation review. This should be coordinated with MRI physics testing, accreditation support, and medical physics consulting.

Frequently Asked Questions (FAQs)

What is MRI relaxometry?

MRI relaxometry is the quantitative measurement of tissue relaxation times — principally T1 (longitudinal) and T2 (transverse) — from a series of MR images acquired with systematically varied timing parameters. Instead of arbitrary gray-scale signal, each voxel is assigned a physical value in milliseconds, which is the basis of parametric maps such as T1, T2, T2*, and extracellular volume (ECV).

Why does T1 and T2 mapping need its own quality control?

Because mapping values are used as diagnostic thresholds and are compared across scanners and over time, small measurement biases matter clinically. Reported T1 and T2 values vary with pulse sequence, field strength, vendor, software version, and phantom temperature, so a relaxometry QC program measures bias against reference values and tracks repeatability to keep results comparable.

What phantoms are used for relaxometry QC?

Two purpose-built systems are common: the ISMRM/NIST system phantom, which contains NMR-characterized arrays of T1 and T2 reference spheres for general quantitative MRI validation, and the T1MES phantom, a regulatory-cleared device designed for cardiac T1 and ECV mapping quality assurance. Both provide known relaxation values spanning the clinically relevant range at 1.5 T and 3 T.

Does phantom temperature really change the measured relaxation time?

Yes. Relaxation times are temperature dependent, so a relaxometry phantom must be allowed to equilibrate to a documented temperature and the temperature recorded with each scan. Reference values are quoted at a specific temperature (often 20 °C for the ISMRM/NIST phantom), and native long-T1 tubes are the most temperature sensitive, so temperature correction or equilibration is required for defensible comparisons.

How is mapping accuracy expressed in a QC program?

Accuracy is expressed as bias — the percentage difference between the measured value and the phantom's reference value — and precision is expressed as the coefficient of variation (CoV) of repeated measurements. Multi-center phantom programs have reported CoVs of roughly 1 percent or less for the best sequence, field-strength, and scanner combinations, which sets a practical target for a stable single-site program.

Is quantitative T1/T2 mapping part of ACR MRI accreditation?

The ACR MRI accreditation phantom tests geometric accuracy, resolution, slice parameters, uniformity, ghosting, and low-contrast detectability — not absolute relaxation times. Quantitative relaxometry QC is a separate, program-specific effort, but it is increasingly expected wherever T1/T2/ECV mapping guides diagnosis, and it complements the accredited scanner QC rather than replacing it.

How often should relaxometry QC be performed?

A practical cadence is a baseline validation at acceptance and after major hardware or software changes, plus a periodic (for example, monthly to quarterly) phantom scan to track drift, with the annual medical physicist evaluation reviewing the trend. Cardiac programs contributing to multi-center work often scan a stability phantom more frequently, such as fortnightly.

Key Takeaways

Relaxometry assigns physical values, so accuracy is clinical. A few-percent bias in T1 or T2 can move a patient across a diagnostic threshold.
The number belongs to the sequence. MOLLI, ShMOLLI, VFA, and inversion-recovery give different T1 values for the same object by design; QC must record the sequence, field strength, and software version. ^{3, 4}
Use a characterized phantom. The ISMRM/NIST system phantom and the T1MES phantom provide traceable reference values across the clinical range. ^{4, 5, 6}
Control temperature. Relaxation times shift with temperature, and long native-T1 tubes are especially sensitive, so equilibrate and record temperature every scan. ⁴
Track bias and repeatability separately. Target a stable CoV near or below 1 percent for the clinical sequence and investigate step changes in bias. ⁴
Relaxometry QC complements, but does not replace, ACR phantom QC. Accreditation validates geometry and uniformity; mapping validation is a separate, program-specific effort. ⁸

Conclusion

Quantitative T1 and T2 mapping gives MRI something it historically lacked: a physical number a clinician can compare to a threshold, to a prior exam, or to another scanner. That number is only as good as the QC behind it. Because relaxation values shift with sequence, field strength, vendor, software, and temperature, a relaxometry program must measure bias against traceable reference values, track repeatability, and control the workflow variables that quietly corrupt the fit.

The medical physicist's role is to turn a promising biomarker into a defensible measurement — selecting a characterized phantom, anchoring the site's clinical sequence to a slow reference, controlling temperature, and trending bias and precision over time. Facilities that treat relaxometry as a quantitative measurement rather than a picture will produce maps that are comparable, reproducible, and clinically trustworthy.

How DRPS Can Help

Diagnostic Radiation Physics Services helps MRI facilities build and validate quantitative imaging programs. For relaxometry, this may include acceptance-time T1/T2 mapping validation against reference phantoms, temperature-controlled QC protocol design, bias and repeatability trending, B1 and flip-angle verification, and integration of mapping QC into the annual MRI physics testing and accreditation support workflow, alongside medical physics consulting.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A quantitative map is a measurement, not just an image — and a measurement deserves a measurement's quality control.

Related Resources

References

Bojorquez JZ, Bricq S, Acquitter C, Brunotte F, Walker PM, Lalande A. What are normal relaxation times of tissues at 3 T? Magn Reson Imaging. 2017;35:69-80. doi:10.1016/j.mri.2016.08.021. doi.org
Keenan KE, Gimbutas Z, Dienstfrey A, Stupic KF, Boss MA, Russek SE, et al. Multi-site, multi-platform comparison of MRI T1 measurement using the system phantom. PLoS One. 2021;16(6):e0252966. doi:10.1371/journal.pone.0252966. doi.org
Captur G, Gatehouse P, Keenan KE, Heslinga FG, Bruehl R, Prothmann M, et al. A medical device-grade T1 and ECV phantom for global T1 mapping quality assurance — the T1 Mapping and ECV Standardization (T1MES) program. J Cardiovasc Magn Reson. 2016;18(1):58. doi:10.1186/s12968-016-0280-z. doi.org
Captur G, Bhandari A, Brühl R, Ittermann B, Keenan KE, Yang Y, et al. T1 mapping performance and measurement repeatability: results from the multi-national T1 mapping standardization phantom program (T1MES). J Cardiovasc Magn Reson. 2020;22(1):31. doi:10.1186/s12968-020-00613-3. doi.org
Sushentsev N, Kaggie JD, Slough RA, Carmo B, Barrett T. Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T. PLoS One. 2021;16(1):e0245970. doi:10.1371/journal.pone.0245970. doi.org
National Institute of Standards and Technology. ISMRM/NIST MRI System Phantom. nist.gov
Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the SCMR endorsed by the EACVI. J Cardiovasc Magn Reson. 2017;19(1):75. doi:10.1186/s12968-017-0389-8. doi.org
American College of Radiology. ACR MRI Quality Control Manual (2015) and MRI Accreditation Program Requirements. acr.org
International Electrotechnical Commission. IEC 62464-1: Magnetic resonance equipment for medical imaging — Part 1: Determination of essential image quality parameters. iec.ch
National Electrical Manufacturers Association. NEMA Standards Publication MS 1 (signal-to-noise ratio) and MS 3 (image uniformity) for diagnostic MRI. nema.org
Radiological Society of North America / Quantitative Imaging Biomarkers Alliance. QIBA Profiles for quantitative MRI. rsna.org